Abnormal osteoclast formation and resorption play a fundamental role in osteoporosis pathogenesis. Over the past two decades, much progress has been made to target osteoclasts. The existing therapeutic drugs include bisphosphonates, hormone replacement therapy, selective estrogen receptor modulators, calcitonin and receptor activator of nuclear factor NF-κB ligand (RANKL) inhibitor (denosumab), etc. Among them, bisphosphonates are most widely used due to their low price and high efficiency in reducing the risk of fracture. However, bisphosphonates still have their limitations, such as the gastrointestinal side-effects, osteonecrosis of the jaw, and atypical subtrochanteric fracture. Based on the current situation, research for new drugs to regulate bone resorption remains relevant. MicroRNAs (miRNAs) are a new group of small, noncoding RNAs of 19–25 nucleotides, which negatively regulate gene expression after transcription. Recent studies discovered miRNAs play a considerable function in bone remodeling by regulating osteoblast and osteoclast differentiation and function. An increasing number of miRNAs have been identified to participate in osteoclast formation, differentiation, apoptosis, and resorption. miRNAs show great promise to serve as biomarkers and potential therapeutic targets for osteoporosis. In this review, we will summarize our current understanding of how miRNAs regulate osteoclastogenesis and function. We will further discuss the approach to develop drugs for osteoporosis based on these miRNA networks.
from #Medicine via ola Kala on Inoreader http://ift.tt/1YvbWa3
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
▼
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
-
▼
Μαρτίου
(699)
-
▼
Μαρ 09
(21)
- Burden of disease and patient-reported outcomes in...
- Nutrients, Vol. 8, Pages 150: Clinical Evaluation ...
- IJERPH, Vol. 13, Pages 302: Meta-Analysis of Cardi...
- IJGI, Vol. 5, Pages 29: Extracting Stops from Nois...
- Nanomaterials, Vol. 6, Pages 45: Atomic Layer Depo...
- Materials, Vol. 9, Pages 182: Imaging Water Thin F...
- Sinusitis, Vol. 1, Pages 44-48: Chronic Rhinosinus...
- Cardiorespiratory fitness and cognitive functionin...
- The psychometric properties of the Turkish Stroke ...
- IJMS, Vol. 17, Pages 349: MicroRNAs in Osteoclasto...
- IJMS, Vol. 17, Pages 349: MicroRNAs in Osteoclasto...
- Sustainability, Vol. 8, Pages 250: Weighing Effici...
- Sensors, Vol. 16, Pages 348: The Design and Optimi...
- Energies, Vol. 9, Pages 175: Optimal Power Managem...
- Information, Vol. 7, Pages 12: CoSpa: A Co-trainin...
- Computed Tomographic Pulmonary Angiographic Findin...
- Association of Quadriceps Muscle Fat With Isometri...
- Multiphase Multi-Detector Row Computed Tomography ...
- Utility of MDCT MIP Postprocessing Reconstruction ...
- Evaluating the Microcirculation of Normal Extraocu...
- Intravoxel Incoherent Motion Diffusion Weighted Ma...
-
▼
Μαρ 09
(21)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.